Efficacy and Safety of Acoramidis in Transthyretin Amyloid CardiomyopathyJulian D. Gillmore, Jonathan C. Fox, Daniel P. Judge et al.|New England Journal of Medicine|2024Cited by 453
Detection of Significant Coronary Artery Disease by Noninvasive Anatomical and Functional ImagingDanilo Neglia, Philipp A. Kaufmann, Gianmario Sambuceti et al.|Circulation Cardiovascular Imaging|2015Cited by 412
Multiparametric Echocardiography Scores for the Diagnosis of Cardiac AmyloidosisMichele Boldrini, Marianna Fontana, Francesco Cappelli et al.|JACC. Cardiovascular imaging|2019Cited by 258
SGLT2 Inhibitor Therapy in Patients With Transthyretin Amyloid CardiomyopathyAldostefano Porcari, Marianna Fontana, Francesco Cappelli et al.|Journal of the American College of Cardiology|2024Cited by 137
Tc-99m labelled bone scintigraphy in suspected cardiac amyloidosisMuhammad U. Rauf, Julian D. Gillmore, Philip N. Hawkins et al.|European Heart Journal|2023Cited by 95